Blog

Latest encapsia news

Revolutionizing technology support for unique trials

Running a rare disease study includes many challenges. It’s a more difficult patient population to access which leads to difficulties in patient recruitment, fewer medical experts available, navigation through often complex regulations, as well as potentially complex study designs. This small population makes these studies expensive as you need more sites, maybe across more countries… Read more »

Sponsors agree the coronavirus pandemic exposed shortcomings of existing processes in clinical trials

Modern technologies support agile processes for clinical trials 95% of attendees to our webinar this week agreed with the central message that processes and supporting technologies commonly used in clinical trials are outdated, and furthermore they contributed to the huge disruption of…

Are we too slavish to the guidance and interpretation of GCP?

This was one of several deliberately thought-provoking questions raised in our webinar last month, “COVID-19: The catalyst for long overdue change in clinical trial technologies and processes”. In the first session, Gurpal Ahluwalia (Partner at BDO Life Sciences) assessed the…

Cmed CTO: The industry has been complacent and suddenly woken up to realize their systems don’t work in a remote world

Question: Your webinar presentation earlier this week was quite provocative. Could you tell us a bit more about your background? TCC: I started writing software and building computers from scratch from a very early age. My father and I ran…

Home Visit app to optimize virtual clinical trials

Cmed Technology announced today the encapsia Home Visit app is now available to capture and manage clinical trial data from patients at home or in the community. The app works seamlessly with all the other encapsia apps, including web EDC (Entry app) and direct data…

A message for our clients, investigator sites and industry partners

The global COVID-19 crisis has fundamentally impacted the way we live our lives as well as the operation of the entire drug development community. During the early stages of the pandemic the Cmed leadership team has implemented a number of…

Cmed’s response to the Coronavirus (COVID-19) pandemic

Thank you for your continued loyalty and trust in Cmed and encapsia during these uncertain times. We are continuously monitoring the evolving circumstances surrounding the COVID-19 outbreak and continue to operate as normal. ~ Our highest priority is to maintain…

eSource as Direct Data Capture

Direct Data Capture (DDC) is one of the four types of eSource (see previous post), and is often what people first think of as eSource. Direct data capture is the process of entering data into the eCRF contemporaneously, rather than transcribing…

The four types of eSource

eSource means different things to different people. You may have never even heard of it, so this is the first in a series of posts which aim to unlock what eSource is. When I ask “What does eSource mean to…